Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

China’s anti-malaria medicine producers face market collapse

20.12.2007
Just three years ago, a global shortage of the anti-malaria medicine artemisinin alarmed medics fighting the killer disease, and spurred scientists who are developing alternative sources of the drug.

Yet a glut of the compound has now saturated the market to such a degree that prices have plummeted, forcing Chinese drug manufacturers out of business.

Artemisinin is extracted from the sweet wormwood plant Artemisia annua, and China is home to 80–90 per cent of the world’s supply. The World Health Organization (WHO) and Novartis have worked together since 2001 to channel much of that medicine into Africa.

But the sudden increase in demand for artemisinin caused a serious shortage, triggering a massive price rise that peaked at 8000 yuan (£537) per kilogram of artemisinin in 2005. To capitalise on this, the number of Chinese artemisinin producers rose from three in 2004 to more than 80 in 2007.

... more about:
»Artemisinin »Who »anti-malaria »producers

China’s annual supply of artemisinin now stands at about 150 tonnes per year – roughly six times what Novartis and the WHO are prepared to buy annually. The resulting surplus has caused the market price of artemisinin to plummet to around 1600 yuan (£107) per kilogram, and the crash has already forced some artemisinin producers out of business.

Novartis points out that it is not responsible for the business crisis. ‘We have repeatedly warned Chinese suppliers that the African anti-malaria market is very small due to their low consumption capacity,’ explained a spokesperson for Novartis China. They added that the WHO is unlikely to buy more artemisinin without an increase in funding for their malaria campaign.

Crucially, the Chinese surplus is still not reaching patients in Africa. Only one Chinese firm – Guangxi-based Guilin Pharmaceutical – has obtained WHO approval (in August 2007) to sell artemisinin in Africa, as part of a combination therapy with another drug.

Chinese market analysts blame the Chinese drug regulator for issuing licenses to produce artemisinin too easily, and for failing to close down unauthorised producers. ‘Local governments should be blamed as well,’ Zhou Chengming, president of Beijing-based Shizhen Traditional Chinese Medicine (TCM) Group told Chemistry World. ‘They have exaggerated artemisinin as the great hope for Chinese pharmaceuticals to go abroad.’

The full text of this Chemistry World story is at:

http://www.rsc.org/chemistryworld/News/2007/December/19120701.asp

Brian Emsley | alfa
Further information:
http://www.chemistryworld.org
http://www.rsc.org/chemistryworld/News/2007/December/19120701.asp

Further reports about: Artemisinin Who anti-malaria producers

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>